Tang JT, Xu MY, Wu NH, Wu F, et al. Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis. Int J Dermatol 2025 Apr 16. doi: 10.1111/ijd.17742.
PMID: 40237138